| Name | Selicrelumab |
|---|
| Description | Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |